INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAB4 Class: CONV BD US

Kohlberg Kravis Roberts & Co. L.P.'s Holding History (CIK: 0001399770)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 51,050,000 Value ($000) $34,235 Avg Close — Range —
Q1 2021
Shares 38,050,000 Value ($000) $24,362 Avg Close — Range —
Q4 2020
Shares 5,000,000 Value ($000) $3,008 Avg Close — Range —